[1] Center for Drug Reevaluation, NMPA. National Center for ADR Monitoring, China[EB/OL].(2020-04-10)[2020-05-20]. https://www.cdr-adr.org.cn/tzgg_home/202004/t20200410_47300.html. [2] ZHANG J, MA J, LI XL.Discussion on syndrome differentiation and disease differentiation of Chinese patent medicine[J]. China Pharm(中国药房), 2011, 22(39): 3649-3650. [3] CHEN P.Analysis of the application of Xiyanping Injection[J].Modern Preventive Medicine(现代预防医学), 2010, 37(15): 3000-3001. [4] LI XX, YIN J, ZHU HR, et al.Evalution on the prescription patterns of Tanreqing injection based on a real world study[J]. Chin Hosp Pharm J(中国医院药学杂志), 2019, 39(23): 2412-2416. [5] WANG LX, YANG W, XIE YM, et al.Real-world clinical application and safety analysis of Xiyanping injection in 4023 patients[J]. Journal of Traditional Chinese Medicine(中医杂志), 2014, 55(7): 571-575. [6] ZHENG QX, YE H.Observation on syndrome differentiation of reduning injection in treating exogenous fever[J]. Clinical Rational Drug Use(临床合理用药), 2013, 6(4C): 76-77. [7] DANG Y, SHI JP, LAN DD, et al.Comparative study of syndrome differentiation and precision medicine under the combination of disease and syndrome[J]. CJTCMP(中华中医药杂志), 2019, 34(12): 5615-5617. [8] Chinese Society of Traditional Chinese medicine, Chinese Society of Traditional Chinese Medicine Lung Diseases, Lung Disease Branch of Chinese National Medical Association. Chinese medical diagnostic and treatment guidelines for community-acquired pneumonia (2018 revision)[J]. Chinese Journal of Traditional Chinese medicine(中医杂志), 2019, 60(4): 350-359. [9] Committee of Pulmonary Diseases, Internal Medicine Branch, Chinese Medical Association. Chinese medical diagnostic and therapeutic guidelines for chronic obstructive pulmonary disease (2011 edition)[J]. Chinese Journal of Traditional Chinese medicine(中医杂志), 2012, 53(1): 80-84. [10] HAO WD, WANG GF.Efficacy of Xiyanping combined with bipap non-invasive ventilation in treatment of AECOPD with syndrome of phlegm-heat obstructing lung complicated with respiratory failure and pneumonia and effects on PCT,strem-1 and quality of life[J], Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2017, 23(14): 193-197. [11] DONG HZ, ZHANG W.The Clinical curative effect of reduning injection on treating acute exacerbation of chronic obstructive pulmonary disease syndrome of phlegm heat obstructing in the lung[J]. JETCM(中国中医急症), 2015, 24(8): 1433-1435. [12] ZHAO Y, SHI S, Huang P.Analysis of clinical use of post-marketing hospital centralized monitoring of Xiyanping injection[J]. Chin J Chin Mater Med(中国中药杂志), 2016, 41(4): 743-747. [13] MENG F, LI XL.Discussion on Chinese medicine proprietary specifi- cation term representation method[J]. Clinical Journal of Traditional Chinese Medicine(中医药临床杂志), 2015, 27(1): 111-112. [14] ZHANG YY.Application of Reduning Injection in clinical treat-ment[J]. Strait Pharmaceutical Journal(海峡药学), 2017, 29(6): 128-130. [15] LIU WL, ZHANG XW, ZHANG B.Clinical analysis of 120 cases of incompatibility of Xiyanping injection with different drug[J]. China Pharmaceuticals(中国药业), 2017, 26(22): 84-85. [16] DU R, YUAN H, YU X.Stability of Reduning,Tanreqing and Xiyanping Injections in clinical use[J]. Chin Hosp Pharm J(中国医院药学杂志), 2016, 36(13): 1095-1099. [17] WANG ZF, ZHANG HR, XIE HM, et al.Expert consensus statement on Xiyanping Injection for respiratory systeminfectious diseases in clinical practice (adults)[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2019, 44(24): 5282-5286. [18] LI GB, TANG QP, YANG QZ.Stability of Reduning injection and its compatibility with cephalosporins[J]. Chinese Journal of Medical Guidance(中国医药指南), 2013, 11(30): 47-49. [19] XI SH.Study on the incompatibility and prevention of Tanreqing injection and other drugs[J]. Everyone's health (Academic)(大家健康(学术版)), 2013, 7(24): 156. [20] LI YH, DU JS, XU T.Discussion on the key points of clinical pharmaceutical care based on the interaction between Chinese and western medicine[J]. Chinese Traditional Patent Medicine(中成药), 2016, 38(1): 222-226. [21] HOU CS, YANG ZH, SUN XB."Cocktail" probe drug method and its application in the study of the effect of traditional Chinese medicine on cytochrome P450[J]. Chin J Pharmacol Toxicol(中国药理学与毒理学杂志), 2013, 27(3): 445-450. [22] LIU Q, LIU KX.Advances in the study of enzymes and transporters-mediated pharmacokinetic mechanism for herb-drug interaction[J].Acta Pharmaceutica Sinica(药学学报), 2015, 50(4): 406-412. [23] LIN Q, ZHANG S.Analysis of 270 cases of adverse drug reactions/events reports caused by Xiyanping injection[J]. Chinese Journal of Pharmacovigilance(中国药物警戒),2012, 9(12): 751-754. [24] YANG XM.Microparticle observation of Tanreqing injection combined with infusion[J]. Chinese Traditional Patent Medicine(中成药), 2006, 28(3): 462-463. [25] WANG YX, LIU T, WANG ZZ,et al.Study on the compatible stability of Reduning injection and solvent[J]. Chin J Chin Mater Med(中国中药杂志), 2010, 35(22): 2990-2992. [26] ZHANG GP, GAO YH, SU P, et al.Development and prospect of liquid preparation of traditional Chinese medicine for lung inhala-tion[J]. Mod Chin Med(中国现代中药), 2019, 21(12): 1732-1738. [27] Chinese Society of Clinical Pharmacy "Consensus of experts on rational drug use in aerosol inhalation therapy" Writing Group. Consensus of experts on rational drug use in aerosol inhalation therapy(2019)[J]. Herald of Medicine(医药导报), 2019, 38(2): 135-146. [28] GENG L, FANG BX, CHEN SM, et al.Meta-analysis of different administrative route of Xiyanping injection for treating respiratory tract infection in children[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine(现代中西医结合杂志), 2014, 23(29): 3214. [29] ZHANG TW.Clinical observation on curative effects of aerobic inhalation of Redu'ning on acute upper respiratory tract infection in children[J]. Clinical Journal of Chinese Medicine(中医临床研究), 2017, 9(34): 61-63. [30] YU L, QIU SJ, TAN XY.Analysis of 110 cases of adverse drug reactions induced by Tanreqing injection[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2015, 12(6): 360-362. |